+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Synthesis Market - Global Forecast 2026-2032- Product Image
RNA Synthesis Market - Global Forecast 2026-2032- Product Image
Sale

RNA Synthesis Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122981
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RNA Synthesis Market is projected to reach USD 5.79 Billion in 2026. It is expected to continue growing at a CAGR of 20.91%, reaching USD 18.45 Billion by 2032.

RNA Synthesis: Executive Summary and Strategic Context

RNA synthesis supports research, diagnostics, therapeutics, vaccines, and emerging cell-based applications by enabling the controlled production of RNA molecules with defined sequence, purity, and functional characteristics. The field spans enzymatic and chemical workflows, template preparation, purification, analytical characterization, and increasingly automated manufacturing processes. Demand is shaped by advances in molecular biology, the expansion of nucleic-acid-based medicine, and the need for reproducible, scalable production under stringent quality requirements.

Platform Maturity, Quality Controls, and Manufacturing Flexibility Are Reshaping RNA Synthesis

RNA synthesis is moving from specialized laboratory activity toward more standardized and configurable production. Improvements in enzyme engineering, modified nucleotides, purification, capping, template design, and process monitoring are helping address recurring challenges such as degradation, heterogeneity, impurities, and batch-to-batch consistency. At the same time, smaller development batches, modular facilities, closed processing, and automation are increasing flexibility across research and clinical workflows. Regulatory expectations for identity, potency, safety, and traceability are reinforcing the importance of integrated analytical and quality systems.

Artificial Intelligence Accelerates Sequence Design, Process Optimization, and Quality Decisions

Artificial intelligence is influencing RNA synthesis primarily through sequence design, structure prediction, codon optimization, impurity-risk assessment, and experimental prioritization. Machine-learning models can help identify sequence features associated with stability, translation, folding, or manufacturability, while process data can support optimization of reaction conditions, purification parameters, and in-process controls. The practical value of these tools depends on representative training data, laboratory validation, explainability, and strong governance. AI is therefore most effective as a decision-support layer integrated with experimental expertise, validated assays, and compliant data infrastructure.

Regional Insights: Capacity, Regulation, and Research Strength Vary Across Six Geographies

North America combines advanced biotechnology research, clinical translation, and established quality infrastructure, supporting innovation in therapeutic and research-grade RNA. Europe benefits from strong academic networks and coordinated regulatory and manufacturing practices, while Asia-Pacific is expanding capabilities through major research programs, pharmaceutical investment, and growing biomanufacturing capacity. Latin America is developing RNA expertise unevenly, with opportunities linked to public-health applications, local research infrastructure, and technology partnerships. The Middle East is investing selectively in life sciences and advanced manufacturing, whereas Africa remains focused on strengthening laboratory capacity, technology access, training, and regional health resilience. Across all regions, reliable cold-chain logistics, skilled personnel, validated analytics, and regulatory alignment remain decisive enabling factors.

Group Insights: Economic Blocs and Alliances Shape Access, Standards, and Collaboration

ASEAN countries present a diverse combination of research capabilities, manufacturing ambitions, and regulatory maturity, creating scope for shared training, harmonized standards, and regional supply networks. BRICS members bring substantial scientific, industrial, and public-health resources, but their markets differ in infrastructure, policy, and technology access. The European Union benefits from coordinated scientific and regulatory frameworks that can support cross-border development and quality consistency. G7 economies provide strong foundations in research, advanced manufacturing, and translational medicine. GCC states are building life-science capacity through investment, partnerships, and diversification strategies. NATO members contribute extensive biomedical research and preparedness capabilities, although collaboration must account for differing national rules and security considerations.

Country Insights: National Capabilities Reflect Distinct Research and Manufacturing Priorities

The United States and Canada combine strong discovery ecosystems with advanced translational and manufacturing capabilities. Germany, France, Italy, Spain, and the United Kingdom benefit from substantial academic, pharmaceutical, and clinical networks, with the United Kingdom also supporting notable genomic and biotechnology activity. China is expanding domestic RNA research, production infrastructure, and application development, while Japan emphasizes precision manufacturing, pharmaceutical quality, and advanced biomedical research. South Korea is strengthening biomanufacturing and technology commercialization. India combines a large scientific workforce with growing pharmaceutical and vaccine capabilities. Australia supports RNA research through academic, medical, and biotechnology institutions. Brazil and Mexico are developing local capacity around health needs, research partnerships, and technology transfer. Russia retains scientific capabilities but faces constraints related to international collaboration, access to equipment, and supply-chain integration.

Actionable Priorities for Leaders: Build Resilient, Data-Driven, Quality-Centered RNA Platforms

Industry leaders should prioritize end-to-end process control rather than optimizing isolated synthesis steps. This includes investing in validated analytical methods, secure data systems, standardized documentation, and flexible facilities that can accommodate different RNA formats and batch requirements. Partnerships with universities, clinical organizations, and specialized technology providers can accelerate method development while reducing duplication. Organizations should also establish clear AI governance, retain human review for consequential decisions, and validate model outputs experimentally. Regional supply diversification, workforce development, contingency planning for critical reagents, and early regulatory engagement can further improve resilience and shorten development cycles.

Research Methodology: Evidence-Based Synthesis of Technology, Policy, and Regional Conditions

This executive summary is based on a structured qualitative assessment of RNA synthesis across technology development, applications, manufacturing practices, analytical quality, artificial intelligence, regulation, infrastructure, and regional capabilities. Insights are organized by the specified regions, country groups, and countries, with emphasis on verifiable industry conditions rather than numerical market claims. The assessment distinguishes established capabilities from emerging activity, considers the role of research and production ecosystems, and avoids unsupported estimates, forecasts, market shares, and company-specific conclusions.

Conclusion: Scalable Quality and Coordinated Innovation Will Define RNA Synthesis Progress

RNA synthesis is becoming a foundational capability across modern biotechnology, but continued progress depends on more than reaction efficiency. Reliable analytical characterization, reproducible manufacturing, regulatory readiness, skilled talent, and resilient supply networks will determine how effectively innovations reach research and clinical use. Artificial intelligence can strengthen this ecosystem when paired with high-quality data and experimental validation. Leaders that combine platform flexibility with disciplined quality management and cross-border collaboration will be best positioned to translate RNA advances into dependable applications.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. RNA Synthesis Market, by Product Type
7.1. Introduction
7.2. Messenger Rna
7.3. Micro Rna
7.4. Single Guide Rna
7.5. Small Interfering Rna
7.6. Transfer Rna
8. RNA Synthesis Market, by Technology
8.1. Introduction
8.2. Chemical Synthesis
8.2.1. Liquid Phase
8.2.2. Solid Phase Phosphoramidite
8.3. Enzymatic Synthesis
8.3.1. In Vitro Transcription
8.3.2. Rolling Circle Transcription
9. RNA Synthesis Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Clinical Diagnostics
9.2.2. Point Of Care Diagnostics
9.3. Research
9.3.1. Basic Research
9.3.2. Drug Discovery
9.4. Therapeutics
9.4.1. Genetic Disorders
9.4.2. Infectious Diseases
9.4.3. Oncology
9.5. Vaccines
9.5.1. Rapid Response Vaccines
9.5.2. Seasonal Vaccines
10. RNA Synthesis Market, by Scale
10.1. Introduction
10.2. Commercial Scale
10.2.1. Bulk Manufacturing
10.2.2. Gmp Production
10.3. Laboratory Scale
10.3.1. Prototyping
10.3.2. Rd Use
11. RNA Synthesis Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. RNA Synthesis Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. RNA Synthesis Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. RNA Synthesis Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aldevron, LLC
16.2. Alnylam Pharmaceuticals, Inc.
16.3. Ansa Biotechnologies, Inc.
16.4. ATDBio Ltd.
16.5. Azenta Life Sciences, Inc.
16.6. BioNTech SE
16.7. ChemGenes Corporation
16.8. CureVac N.V.
16.9. EnPlusOne Biosciences, Inc.
16.10. Eurofins Genomics Germany GmbH
16.11. GenScript Biotech Corporation
16.12. Integrated DNA Technologies, Inc.
16.13. Kilobaser, Inc.
16.14. Merck KGaA
16.15. Moderna, Inc.
16.16. New England Biolabs, Inc.
16.17. Sarepta Therapeutics, Inc.
16.18. Thermo Fisher Scientific Inc.
16.19. Twist Bioscience Corporation
16.20. WAVE Life Sciences Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global RNA Synthesis Market, Years Considered for the Study
FIGURE 2. Global RNA Synthesis Market, Research Design
FIGURE 3. Global RNA Synthesis Market, Research Framework
FIGURE 4. Global RNA Synthesis Market, Data Triangulation
FIGURE 5. Global RNA Synthesis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global RNA Synthesis Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global RNA Synthesis Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global RNA Synthesis Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global RNA Synthesis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global RNA Synthesis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global RNA Synthesis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global RNA Synthesis Market Size, by Scale, 2025 vs 2032 (%)
FIGURE 13. Global RNA Synthesis Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global RNA Synthesis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global RNA Synthesis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global RNA Synthesis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global RNA Synthesis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global RNA Synthesis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global RNA Synthesis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global RNA Synthesis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global RNA Synthesis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global RNA Synthesis Market Segmentation & Coverage
TABLE 2. Global RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 3. Global RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Messenger Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Messenger Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Messenger Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Micro Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Micro Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Micro Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Single Guide Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Single Guide Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Single Guide Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Small Interfering Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Small Interfering Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Small Interfering Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Transfer Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Transfer Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Transfer Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 20. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Liquid Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Liquid Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Liquid Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Solid Phase Phosphoramidite Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Solid Phase Phosphoramidite Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Solid Phase Phosphoramidite Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Enzymatic Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Enzymatic Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Enzymatic Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global In Vitro Transcription Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global In Vitro Transcription Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global In Vitro Transcription Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Rolling Circle Transcription Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Rolling Circle Transcription Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Rolling Circle Transcription Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 39. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Point Of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Point Of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Point Of Care Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Basic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Basic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Basic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Genetic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Genetic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Genetic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Rapid Response Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Rapid Response Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Rapid Response Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Seasonal Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Seasonal Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Seasonal Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 79. Global Commercial Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Commercial Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Commercial Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Bulk Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Bulk Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Bulk Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Gmp Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Gmp Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Gmp Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Laboratory Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Laboratory Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Laboratory Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Prototyping Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Prototyping Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Prototyping Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Rd Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Rd Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Rd Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. North America RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. North America RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. North America RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 129. North America RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 130. North America RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. North America RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 132. North America RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 133. North America RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 134. North America RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 135. North America RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 136. North America RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 137. North America RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 138. North America RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Latin America RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Latin America RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. Latin America RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. Latin America RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 143. Latin America RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 144. Latin America RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Latin America RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 146. Latin America RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 147. Latin America RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 148. Latin America RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 149. Latin America RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 150. Latin America RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 151. Latin America RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 152. Latin America RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Europe RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Europe RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Europe RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. Europe RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 157. Europe RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 158. Europe RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Europe RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 160. Europe RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 161. Europe RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 162. Europe RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 163. Europe RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 164. Europe RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 165. Europe RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 166. Europe RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Middle East RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Middle East RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. Middle East RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 171. Middle East RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 172. Middle East RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Middle East RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 174. Middle East RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 175. Middle East RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 176. Middle East RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 177. Middle East RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 178. Middle East RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 179. Middle East RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 180. Middle East RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Africa RNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Africa RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Africa RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Africa RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 185. Africa RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 186. Africa RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Africa RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 188. Africa RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 189. Africa RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 190. Africa RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 191. Africa RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 192. Africa RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 193. Africa RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 194. Africa RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Global RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. ASEAN RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. ASEAN RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 200. ASEAN RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 201. ASEAN RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. ASEAN RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 203. ASEAN RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 204. ASEAN RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 205. ASEAN RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 206. ASEAN RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 207. ASEAN RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 208. ASEAN RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 209. ASEAN RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. GCC RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. GCC RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. GCC RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. GCC RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 214. GCC RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 215. GCC RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. GCC RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 217. GCC RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 218. GCC RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 219. GCC RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 220. GCC RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 221. GCC RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 222. GCC RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 223. GCC RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. European Union RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. European Union RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. European Union RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. European Union RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 228. European Union RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 229. European Union RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. European Union RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 231. European Union RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 232. European Union RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 233. European Union RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 234. European Union RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 235. European Union RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 236. European Union RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 237. European Union RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. BRICS RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. BRICS RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. BRICS RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. BRICS RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 242. BRICS RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 243. BRICS RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. BRICS RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 245. BRICS RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 246. BRICS RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 247. BRICS RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 248. BRICS RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 249. BRICS RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 250. BRICS RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 251. BRICS RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. G7 RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. G7 RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. G7 RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. G7 RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 256. G7 RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 257. G7 RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. G7 RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 259. G7 RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 260. G7 RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 261. G7 RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 262. G7 RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 263. G7 RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 264. G7 RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 265. G7 RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. NATO RNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. NATO RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. NATO RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. NATO RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 270. NATO RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 271. NATO RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. NATO RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 273. NATO RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 274. NATO RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 275. NATO RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 276. NATO RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 277. NATO RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 278. NATO RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 279. NATO RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Global RNA Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 282. United States RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. United States RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 284. United States RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 285. United States RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 286. United States RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. United States RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 288. United States RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 289. United States RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 290. United States RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 291. United States RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 292. United States RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 293. United States RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 294. United States RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Canada RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 296. Canada RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Canada RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 298. Canada RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 299. Canada RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 300. Canada RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Canada RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 302. Canada RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 303. Canada RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 304. Canada RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 305. Canada RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 306. Canada RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 307. Canada RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 308. Canada RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Mexico RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 310. Mexico RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. Mexico RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 312. Mexico RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 313. Mexico RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 314. Mexico RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 315. Mexico RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 316. Mexico RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 317. Mexico RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 318. Mexico RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 319. Mexico RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 320. Mexico RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 321. Mexico RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 322. Mexico RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Brazil RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 324. Brazil RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. Brazil RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 326. Brazil RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 327. Brazil RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 328. Brazil RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. Brazil RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 330. Brazil RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 331. Brazil RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 332. Brazil RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 333. Brazil RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 334. Brazil RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 335. Brazil RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 336. Brazil RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. United Kingdom RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 338. United Kingdom RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. United Kingdom RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 340. United Kingdom RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 341. United Kingdom RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 342. United Kingdom RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. United Kingdom RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 344. United Kingdom RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 345. United Kingdom RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 346. United Kingdom RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 347. United Kingdom RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 348. United Kingdom RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 349. United Kingdom RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 350. United Kingdom RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 351. Germany RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 352. Germany RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 353. Germany RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 354. Germany RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 355. Germany RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 356. Germany RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 357. Germany RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 358. Germany RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 359. Germany RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 360. Germany RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 361. Germany RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 362. Germany RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 363. Germany RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 364. Germany RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 365. France RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 366. France RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 367. France RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 368. France RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 369. France RNA Synthesis Market Size, by Enzymatic Synthesis, 2017-2032 (USD Million)
TABLE 370. France RNA Synthesis Market Size, by Application, 2017-2032 (USD Million)
TABLE 371. France RNA Synthesis Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 372. France RNA Synthesis Market Size, by Research, 2017-2032 (USD Million)
TABLE 373. France RNA Synthesis Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 374. France RNA Synthesis Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 375. France RNA Synthesis Market Size, by Scale, 2017-2032 (USD Million)
TABLE 376. France RNA Synthesis Market Size, by Commercial Scale, 2017-2032 (USD Million)
TABLE 377. France RNA Synthesis Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 378. France RNA Synthesis Market Size, by End User, 2017-2032 (USD Million)
TABLE 379. Russia RNA Synthesis Market Size, 2017-2032 (USD Million)
TABLE 380. Russia RNA Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 381. Russia RNA Synthesis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 382. Russia RNA Synthesis Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 383. Russia RNA Synthe

Companies Mentioned

  • Aldevron, LLC
  • Alnylam Pharmaceuticals, Inc.
  • Ansa Biotechnologies, Inc.
  • ATDBio Ltd.
  • Azenta Life Sciences, Inc.
  • BioNTech SE
  • ChemGenes Corporation
  • CureVac N.V.
  • EnPlusOne Biosciences, Inc.
  • Eurofins Genomics Germany GmbH
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Kilobaser, Inc.
  • Merck KGaA
  • Moderna, Inc.
  • New England Biolabs, Inc.
  • Sarepta Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • WAVE Life Sciences Ltd.

Related Topics

Related Reports

Single Cell RNA Purification Kit Market - Global Forecast 2026-2032 - Product Image

Single Cell RNA Purification Kit Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
RNA Therapy Market - Global Forecast 2026-2032 - Product Image

RNA Therapy Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
gRNA - Global Strategic Business Report - Product Image

gRNA - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From

About the RNA Synthesis Market

RNA Synthesis is a process used in biotechnology to create RNA molecules from DNA templates. It is used in a variety of applications, such as gene expression studies, protein engineering, and drug discovery. The process involves the use of enzymes to transcribe DNA into RNA, which is then purified and modified to create the desired molecule. The RNA Synthesis market is an important part of the biotechnology industry, as it provides the tools and materials necessary for the development of new treatments and therapies. It is also used in research and development, as well as in the production of diagnostic tests. Some of the companies in the RNA Synthesis market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, and Promega Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.